Table 4.
Overall (n=2880) | Blacks, n
|
Whites, n
|
|||
---|---|---|---|---|---|
Men (n=708) | Women (n=1443) | Men (n=248) | Women (n=481) | ||
ACE inhibitors† | 926 | 196 | 453 | 106 | 171 |
ACE receptor blockers‡ | 423 | 92 | 227 | 30 | 74 |
Calcium channel blockers§ | 873 | 196 | 500 | 51 | 126 |
β-Blockers† | 487 | 94 | 215 | 52 | 126 |
Any diuretic‡ | 835 | 164 | 468 | 62 | 141 |
Types of diuretic | |||||
Thiazide diuretics | 645 | 124 | 359 | 49 | 113 |
Loop diuretics | 192 | 41 | 106 | 14 | 31 |
Potassium-sparing diuretics: | 9 | 3 | 4 | 1 | 1 |
aldosterone antagonists | |||||
Potassium-sparing diuretics: | 74 | 17 | 45 | 1 | 11 |
sodium channel blockers | |||||
α1-Blockers‡ | 29 | 8 | 12 | 4 | 5 |
α2-Agonists§ | 175 | 40 | 102 | 12 | 21 |
Vasodilators‡ | 4 | 0 | 4 | 0 | 0 |
Other‡ | 153 | 44 | 75 | 8 | 26 |
ACE indicates angiotensin-converting enzyme.
Data on type of antihypertensive medication used were missing for ≈18% of participants who reported medication use. More than 94% were on at least 1 of the major classes of agents (ACE, ACE receptor blockers, calcium channel blockers, β-blockers, and diuretic), 44% were on ≥2 classes, and 10% were on ≥3 classes.
Compared with whites, blacks were less likely to be on these classes of antihypertensive medications (P<0.01).
Compared with whites, blacks were more likely to be on these classes of antihypertensive medications (P<0.01).
Black vs white comparisons were not significant (P>0.05).